Caroline Saucier Selected Research

prostein

1/2017

Expression of SOCS1 and the downstream targets of its putative tumor suppressor functions in prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Caroline Saucier Research Topics

Disease

18	Neoplasms (Cancer) 01/2019 - 03/2002
5	Neoplasm Metastasis (Metastasis) 02/2017 - 03/2002
4	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 09/2010
2	Hepatocellular Carcinoma (Hepatoma) 09/2017 - 12/2011
2	Triple Negative Breast Neoplasms 01/2017 - 10/2016
2	Carcinogenesis 02/2014 - 11/2005
1	Hypoxia (Hypoxemia) 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 01/2017
1	Melanoma (Melanoma, Malignant) 06/2016
1	Inflammation (Inflammations) 01/2016
1	Breast Neoplasms (Breast Cancer) 02/2014
1	Wounds and Injuries (Trauma) 12/2010
1	Infections 12/2010

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 09/2017 - 03/2002
6	CytokinesIBA 09/2017 - 12/2011
4	Proto-Oncogene Proteins c-metIBA 01/2017 - 11/2005
3	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2018 - 09/2010
3	Phosphotransferases (Kinase)IBA 04/2014 - 03/2002
3	tyrosine receptor (receptor, tyrosine)IBA 04/2014 - 03/2002
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2018 - 09/2010
2	Growth Factor ReceptorsIBA 01/2018 - 02/2014
2	MicroRNAs (MicroRNA)IBA 01/2017 - 01/2014
2	Messenger RNA (mRNA)IBA 01/2017 - 01/2017
2	Oncogene Proteins (Oncogene Protein)IBA 02/2004 - 03/2002
1	Lysophosphatidic Acid ReceptorsIBA 01/2019
1	LipidsIBA 01/2019
1	Phosphates (Orthophosphate)IBA 01/2019
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2019
1	EnzymesIBA 01/2019
1	lysophosphatidic acidIBA 01/2019
1	Peptide Hydrolases (Proteases)FDA Link 02/2017
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 02/2017
1	Biomarkers (Surrogate Marker)IBA 02/2017
1	salicylhydroxamic acid (SHAM)IBA 01/2017
1	prosteinIBA 01/2017
1	Androgen Receptors (Androgen Receptor)IBA 01/2017
1	Chloroquine (Aralen)FDA LinkGeneric 10/2016
1	Peptides (Polypeptides)IBA 06/2016
1	Histocompatibility Antigens Class IIBA 06/2016
1	CarcinogensIBA 01/2016
1	GTP Phosphohydrolases (GTPases)IBA 02/2014
1	Monomeric GTP-Binding ProteinsIBA 02/2014
1	ErbB Receptors (EGF Receptor)IBA 02/2014
1	Epidermal Growth Factor (EGF)IBA 02/2014
1	Janus KinasesIBA 01/2014
1	Tyrosine Kinase InhibitorsIBA 01/2014
1	Interleukin-6 (Interleukin 6)IBA 12/2011
1	Small Interfering RNA (siRNA)IBA 12/2010
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 12/2010
1	matrigelIBA 12/2010
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 04/2006
1	Mitogen-Activated Protein KinasesIBA 11/2005
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2004
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2002

Therapy/Procedure

2	Radiotherapy 02/2017 - 01/2017
2	Aftercare (After-Treatment) 02/2017 - 10/2016
1	Intravenous Injections 06/2016
1	Subcutaneous Injections 12/2010